Keloid Scarring: Treatment and Pathophysiology

• Status: Unknown status
• Trial end date: 2015-01-01

Summary

To clarify the mechanisms of Keloid scar formation.

Elucidate the action and therapeutic value of 5-FU in Keloid scar treatment

Identify the genetic link with Keloid scar formation.

Quantify the psychological/social impact in keloid scarring patients

• Phase: Phase 4

Details

• Lead Sponsor: Queen Mary University of London
• Treatments: Fluorouracil; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide